Topics

U.S. FDA approves Gilead's HIV prevention treatment

11:40 EDT 3 Oct 2019 | Reuters

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's drug, Descovy, to reduce the risk of sexually acquired HIV infection.

Original Article: U.S. FDA approves Gilead's HIV prevention treatment

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA approves Gilead's HIV prevention treatment"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...